Lee Young-chul acquires 7.7M convertible bonds of Aprogen Biologics, securing 34.83% stake
Filer Lee Young-chul acquired 7,703,703 convertible bonds of Aprogen Biologics (holding ratio 34.83%) via over-the-counter purchase. Purpose is simple investment.
Acquisition price per convertible bond is KRW 3,375, total acquisition amount approximately KRW 26 billion.
No prior holdings (new report). No special related parties.